Long-term outcome of reduced-intensity allogeneic hematopoietic SCT in patients with AML in CR

A total of 36 consecutive patients with AML in CR underwent reduced-intensity allogeneic hematopoietic SCT (RISCT) with fludarabine and melphalan conditioning. All patients were ineligible for myeloablative transplantation because of age or comorbidity. In total, 30 patients were in first CR and six...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Bone Marrow Transplant
Autors principals: Popat, U, de Lima, MJ, Saliba, RM, Anderlini, P, Andersson, BS, Alousi, AM, Hosing, C, Nieto, Y, Parmar, S, Khouri, IF, Kebriaei, P, Qazilbash, M, Champlin, RE, Giralt, SA
Format: Artigo
Idioma:Inglês
Publicat: 2011
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4320641/
https://ncbi.nlm.nih.gov/pubmed/21423123
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bmt.2011.61
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars